CClinicalTrials.gg
CompletedNCT05728450Updated Aug 11, 2025

Effect of Laser Puncture on Liver Enzymes Post Burn

An interventional study of Light amplification by stimulated emission of radiation (LASER) in Burns, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

Procedures of laser puncture:

  • The treatment procedures will start after the patient's release from the intensive care unit.
  • The patient will be in a comfortable position.
  • The patient will wear protective eyeglasses.
  • The points for the application of laser acupuncture will be cleaned before application. All patients in the study group will be submitted to an infrared diode laser, wavelength 808 nm, Pulse duration: 200 ms, Power density: 0.4 W/cm2, energy density 4 J/cm2.
  • The plug of the laser unit will be inserted into the main current supply and the on/off switch will be switched on. The therapy form will be selected from the main menu and then the parameters will be set.
  • Acupuncture detector (Pointer Excel II) will be used for the definite location of acupuncture points.
  • Laser probe will be placed in contact with the skin perpendicular over the body acupoints Zusanli (ST36), Taichong (LR3), Tanyinjiao (SP6), Ganshu (BL18), Yan-glingquan (GB34) and Zhongwan (RN12) in both sides, with a duration of 90 sec for each point three times per week for a month.
Read the detailed description

Thirty patients with partial thickness burn with burned body surface area (BBSA) about 30% to 50% will participate in this study after their release from the intensive care unit. Their ages will be ranged from 20 to 45 years. The participants will be selected from Orabi hospital and randomly distributed into two equal groups.

1. Group A (Study group): This group includes 15 burned patients who will receive laser puncture for one month (3 times/week) in addition to their physical therapy program (splinting, stretching ex. and ROM ex.) and medical treatment.

1. Group B (Control group): This group includes 15 burned patients who will receive their physical therapy program (splinting, stretching ex., strengthening ex. and ROM ex.) and medical treatment.

Criteria for the patient selection:

- Inclusion Criteria:

The subject selection will be according to the following criteria:

  • Age ranges between 20-45 years.
  • Male and female patients will participate in the study.
  • All patients who have burned with BBSA about 30% to 50% with acupoints are unaffected.
  • All patients enrolled on the study will have their informed consent.
  • Exclusion Criteria:

The potential participants will be excluded if they meet one of the following criteria:

  • Burn at areas of acupuncture points.
  • Lower limb amputation.
  • History of liver diseases.
  • Body mass index (BMI=kg/cm2)\<30%.

Procedures of laser puncture:

  • The treatment procedures will start after the patient's release from the intensive care unit.
  • The patient will be in a comfortable position.
  • The patient will wear protective eyeglasses.
  • The points for the application of laser acupuncture will be cleaned before application. All patients in the study group will be submitted to an infrared diode laser, wavelength 808 nm, Pulse duration: 200 ms, Power density: 0.4 W/cm2, energy density 4 J/cm2.
  • The plug of the laser unit will be inserted into the main current supply and the on/off switch will be switched on. The therapy form will be selected from the main menu and then the parameters will be set.
  • Acupuncture detector (Pointer Excel II) will be used for the definite location of acupuncture points.
  • Laser probe will be placed in contact with the skin perpendicular over the body acupoints Zusanli (ST36), Taichong (LR3), Tanyinjiao (SP6), Ganshu (BL18), Yan-glingquan (GB34) and Zhongwan (RN12) in both sides, with a duration of 90 sec for each point three times per week for a month.

The anatomical locations of acupoints used:

  1. Zusanli (ST36) acupoint is located on the lateral side of the lower leg, one hands' breadth below the knee crease and one finger's breadth lateral to the shin bone.
  2. Tanyinjiao (SP6) acupoint is located on the inside of the lower leg, one hands' breadth above the prominence of the medial malleolus.
  3. Taichong (LR3) acupoint is located on the dorsum of the foot in the distal hollow at the junction of the first and second metatarsal bone.
  4. Yan-glingquan (GB34) acupoint is located below the outside of the knee, in a tender depression 1 body inch anterior and inferior to the head of the fibula.
  5. Ganshu (BL18) acupoint is located two forefingers width lateral to the lower border of the spinous process of the 9th thoracic vertebra.
  6. Zhongwan (RN12) acupoint is located on the anterior median line of the upper abdomen, proximal 5 fingers breadth above the belly button.
02

Conditions studied

  • Burns

Browse trials for

03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 30 is below the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The subject selection will be according to the following criteria:
  • Age ranges between 20-45 years.
  • Male and female patients will participate in the study.
  • All patients who have burned with BBSA about 30% to 50% with acupoints are unaffected.
  • All patients enrolled on the study will have their informed consent.

Exclusion criteria

Exclusion Criteria:

  • The potential participants will be excluded if they meet one of the following criteria:
  • Burn at areas of acupuncture points.
  • Lower limb amputation.
  • History of liver diseases.
  • Body mass index (BMI=kg/cm2)\<30%.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Study group

    This group includes 15 burned patients who will receive laser puncture for one month (3 times/week) in addition to their physical therapy program (splinting, stretching ex. and ROM ex.) and medical treatment.

    Device: Light amplification by stimulated emission of radiation (LASER)

  • No intervention
    Control group

    This group includes 15 burned patients who will receive their physical therapy program (splinting, stretching ex., strengthening ex. and ROM ex.) and medical treatment.

Interventions

  • DeviceLight amplification by stimulated emission of radiation (LASER)

    * The points for application of laser acupuncture will be cleaned before application. All patients in the study group will be submitted to infrared diode laser, wavelength 808 nm, Pulse duration: 200 ms, Power density: 0.4 W/cm2, energy density 4 J/cm2 (Chow, 2001). * The plug of the laser unit will inserted into the main current supply and on/off switch will be switched on. The therapy form will be selected from the main menu and then the parameters will be set. * Acupuncture detector (Pointer Excel II) will be used for definite location of acupuncture points

06

What researchers measure

Primary outcomes

  1. EFFECT OF LASER PUNCTURE ON LIVER ENZYMES POST BURN.

    liver enzymes level (AST and ALT enzymes)

    Time frame: one month

07

Study locations

1 site
  • Faculty of Physical Therapy Cairo University
    Giza, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05728450
Lead sponsor
Cairo University
Responsible party
Aya Gamal Fawzy El-Sayed (Lecturer of physical therapy of surgery, Cairo University) — Principal investigator
First posted
Feb 15, 2023
Start date
Feb 19, 2023
Primary completion
Mar 19, 2023
Completion
Apr 19, 2023
Last update
Aug 11, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion